Miracle Mile Advisors, LLC Repligen Corp Transaction History

Miracle Mile Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$161.19 - $257.96 $169,249 - $270,858	-1,050 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$247.59 - $304.47 $7,427 - $9,134	-30 Reduced 2.78%	1,050 $278,000
Q2 2021 Jul 28, 2021	SELL	$165.87 - $220.95 $3,317 - $4,419	-20 Reduced 1.82%	1,080 $216,000
Q4 2020 Jan 19, 2021	BUY	$148.08 - $206.57 $162,888 - $227,227	1,100 New	1,100 $211,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Miracle Mile Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Miracle Mile Advisors, LLC with notifications on news.